VRAYLAR, an atypical antipsychotic medication, received its Notice of Compliance from Health Canada on April 22, 2022. Following the positive recommendation from INESSS issued in October 2022, VRAYLAR completed negotiations… Read More
The Province is moving forward with new guidelines to protect students and reduce the risks and harms of toxic-drug poisonings. “Our post-secondary campuses should be a safe space for students,… Read More
The most widely used diagnostic tests for syphilis can’t differentiate between an active infection and a past one. They’re not good at identifying early and late disease and can’t diagnose… Read More
Calgary, AB — Santis is pleased to welcome Tyler Shandro to the team as a Senior Advisor. As the former Minister of Health for the Government of Alberta, Tyler led… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that it has entered into a Material Transfer Agreement with a… Read More
